BetterLife To Present BETR-001 Preclinical Data at the Upcoming Canadian Association for Neuroscience Conference
21 avr. 2022 08h00 HE
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, April 21, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
BetterLife’s BETR-001 Demonstrates BETR-001 Anti-depressant Activity in Preclinical Models of Depression
06 avr. 2022 08h00 HE
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, April 06, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
Ontario to Get Dedicated Mental Health Facility for First Responders
03 mars 2022 18h09 HE
|
Police Association of Ontario
Toronto, March 03, 2022 (GLOBE NEWSWIRE) -- The Police Association of Ontario (PAO) is thrilled that Ontario has announced a dedicated mental health facility for first responders thanks to...
BetterLife Lead Drug (BETR-001) Promotes Structural Neural Plasticity in Preclinical Model
15 févr. 2022 08h00 HE
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, Feb. 15, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
BetterLife Launches New Corporate Website
10 févr. 2022 08h00 HE
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, Feb. 10, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR/ OTCQB: BETRF/ FRA: NPAU), an emerging biotech company focused on the...
Psychable Founders To Be Featured Speakers At Meet Delic Conference
05 nov. 2021 09h29 HE
|
Psychable, Inc.
LOS ANGELES, Nov. 05, 2021 (GLOBE NEWSWIRE) -- Meet Delic is shaping up to be one of the largest psychedelic industry gatherings of the year including Jason Silva, Aubrey Marcus, Dr. Carl Hart,...
COMPASS Pathways launches new podcast “Everyone has a story: talking about mental health”
30 juin 2021 07h00 HE
|
COMPASS Pathfinder Ltd.
London, UK – 30 June 2021 COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in...
COMPASS Pathways completes COMP360 psilocybin therapy administration for 216 patients in large-scale phase IIb psilocybin therapy trial for treatment-resistant depression
28 juin 2021 07h00 HE
|
COMPASS Pathfinder Ltd.
London, UK, June 28, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in...
COMPASS Pathways becomes Founding Supporter of the British Neuroscience Association’s inaugural Scholars programme
23 juin 2021 07h00 HE
|
COMPASS Pathfinder Ltd.
Programme aims to support students from under-represented ethnic groups London, UK – 23 June 2021 COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to...
COMPASS Pathways plc to participate in JMP Securities and H.C. Wainwright investor conferences
08 juin 2021 07h00 HE
|
COMPASS Pathfinder Ltd.
LONDON, June 08, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health,...